Nutraplus India has commenced commercial production in its new plant at Tarapur for anti-malarial drug LUMEFANTRINE. Previously company was engaged in the manufacturing of Intermediate of the same drug (i.e. n-2 stage) at its existing factory and was selling to the various pharma companies.
Now company is manufacturing the final end product (i.e. LUMEFANTRINE) on full fledge basis at company's new production facilities. The company has obtained necessary approvals and has commenced the commercial production of LUMEFANTRINE. This is a forward integration and shall result in better margin. The company expects to achieving full production capacities in next 3 month in its plant.
Nutraplus India was incorporated as a private limited company in February 1990. The company’s manufacturing unit was commissioned to make APIs and intermediates.
